Stay updated with breaking news from Thomas Sandgaard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zynex (NASDAQ:ZYXI – Get Rating) updated its FY 2023 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.40-$0.50 for the period, compared to the consensus estimate of $0.47. The company issued revenue guidance of $180.00 million-$200.00 million, compared to the consensus revenue estimate of $191.24 million. Zynex also updated its […]
Zynex (NASDAQ:ZYXI – Get Rating) issued an update on its first quarter 2023 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0-$0.03 for the period, compared to the consensus earnings per share estimate of $0.01. The company issued revenue guidance of $39.00 million-$41.00 million, compared to the consensus revenue estimate […]
/PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced that Thomas Sandgaard, its Chief Executive Officer (the "Selling Stockholder"), has...
/PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...
/PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced its intent to offer, subject to market conditions and other factors, $50 million...